Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07343674Recruiting

PERFECT - Portuguese Evolut Registry Studying the Outcomes of Medtronic Evolut™ FX+ TAVI System by Evaluating an Optimal Care Pathway for TAVI

Role: lead

NCT07477405Not Yet Recruiting

Drug-coatEd Balloon Multicentric Registry in Spain and PORTugal

Role: lead

NCT06818435Recruiting

Portuguese Registry With Meril Myval THV Series - MyPORTuVal Registry

Role: lead

NCT01867801Unknown

Portuguese Registry on Interventional Cardiology

Role: collaborator

NCT01835808Completed

Portuguese Study on The Evaluation of FFR Guided Treatment of Coronary Disease

Role: collaborator

All 5 trials loaded